Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.
Front Immunol
; 14: 1212209, 2023.
Article
in En
| MEDLINE
| ID: mdl-37435071
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Surfactants
/
Anti-Infective Agents
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland